Genetics of osteoporosis

Area of Science:

• Genetics
• Bone Biology
• Osteoporosis Research

Background:

• Osteoporosis is a skeletal disease defined by low bone mineral density (BMD) and deteriorating bone microarchitecture, increasing fracture risk.
• Bone mineral density (BMD) is a complex, genetically influenced trait, with heritability estimated between 50-90% based on family and twin studies.
• Genetic factors play a significant role in the development of osteoporosis and susceptibility to osteoporotic fractures.

Purpose of the Study:

• To review the genetic underpinnings of osteoporosis.
• To highlight the role of genetic research in identifying diagnostic and therapeutic targets for osteoporosis.

Main Methods:

• Review of candidate gene approaches and genome-wide association studies (GWAS).
• Analysis of single-nucleotide polymorphisms (SNPs) associated with BMD, osteoporosis, and fractures.
• Mapping of identified SNPs to genes involved in nuclear receptors and WNT-β-catenin signaling pathways.

Main Results:

• Numerous single-nucleotide polymorphisms (SNPs) have been identified that are associated with low BMD, osteoporosis, and osteoporotic fractures.
• These genetic variations are often located near or within genes critical for bone metabolism, including those encoding nuclear receptors and WNT-β-catenin signaling proteins.
• Genetic studies have elucidated key pathways involved in bone health and disease.

Conclusions:

• Understanding the genetic architecture of osteoporosis is crucial for advancing the field.
• Identified genetic factors and pathways provide novel targets for the development of diagnostic tools and therapeutic interventions for osteoporosis.
• Further genetic research promises to enhance the clinical management of osteoporosis.